Fig. 3.

Western blots (WB) performed on frontal cortex of mice treated with haloperidol decanoate (N = 11) or vehicle (N = 9) for 2 weeks. (A) No differences were observed in total AMPK. (B) Activated pGSK-3β was reduced in haloperidol treated mice. (C) The ratio of active/total pAMPK-3β/total AMPK was reduced in haloperidol treated mice, suggesting an inactivation of the kinase. The insert displays typical gel lanes from immunoblots used for quantitative analyses with ImageJ.